Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Completed · Phase 1
Conditions studied: Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma, Vaginal Cancer, Vulvar Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I trial is studying the side effects and best dose of topotecan in treating patients with gynecologic cancer that cannot be removed by surgery.
Key facts
- Study ID
- NCT00842452
- Run by
- Steven Waggoner, MD
- People needed
- 26
- Starts
- 2009-02-01
- Expected to finish
- 2011-04-01
- Last updated by the study team
- 2013-04-05
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.